Search results
Q2 2024 EPS Estimates for Bruker Co. Reduced by Leerink Partnrs (NASDAQ:BRKR)
ETF DAILY NEWS· 7 days agoBruker Co. (NASDAQ:BRKR – Free Report) – Stock analysts at Leerink Partnrs dropped their Q2 2024 earnings per share (EPS) estimates for Bruker in a research report issued ...
Citigroup Lowers Axsome Therapeutics (NASDAQ:AXSM) Price Target to $125.00
ETF DAILY NEWS· 5 days agoAxsome Therapeutics (NASDAQ:AXSM – Get Free Report) had its price objective reduced by Citigroup from $127.00 to $125.00 in a research note issued to investors on Tuesday, Benzinga reports.
Tango Therapeutics (NASDAQ:TNGX) Stock Price Down 7.3%
ETF DAILY NEWS· 2 days agoTango Therapeutics, Inc. (NASDAQ:TNGX – Get Free Report)’s share price traded down 7.3% on Friday . Piper Sandler assumed coverage on shares of Tango Therapeutics in a research note on Monday ...
ACADIA Pharmaceuticals (NASDAQ:ACAD) Price Target Cut to $22.00 by Analysts at Bank of America
ETF DAILY NEWS· 3 days agoThe brokerage currently has a “neutral” rating on the biopharmaceutical company’s stock. Bank of America‘s price objective would indicate a potential upside of 44.64% from ...
HC Wainwright Weighs in on GH Research PLC’s Q2 2024 Earnings (NASDAQ:GHRS)
ETF DAILY NEWS· 3 days agoGH Research PLC (NASDAQ:GHRS – Free Report) – Research analysts at HC Wainwright lowered their Q2 2024 earnings per share (EPS) estimates for GH Research in a research note issued to investors ...
SAB Biotherapeutics (NASDAQ:SABS) Shares Up 3.8%
ETF DAILY NEWS· 6 days agoShares of SAB Biotherapeutics, Inc. (NASDAQ:SABS – Get Free Report) shot up 3.8% during mid-day trading on Tuesday . The company traded as high as $4.50 and last traded at $4.09. 14,549 shares ...
Immunic, Inc. (NASDAQ:IMUX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 days agoImmunic, Inc. (NASDAQ:IMUX) Q1 2024 Earnings Call Transcript May 8, 2024 Immunic, Inc. isn’t one of...
Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate Update
WTNH-TV New Haven· 5 days agoImmunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today ...
